Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Débora B Vieira & Lionel F Gamarra. (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International Journal of Nanomedicine 11, pages 5381-5414.
Read now
Read now
Xavier Thomas & Caroline Le Jeune. (2016) Treating adults with acute lymphocytic leukemia: new pharmacotherapy options. Expert Opinion on Pharmacotherapy 17:17, pages 2319-2330.
Read now
Read now
Leila Karami & Seifollah Jalili. (2015) Effects of cholesterol concentration on the interaction of cytarabine with lipid membranes: a molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 33:6, pages 1254-1268.
Read now
Read now
Donato Cosco, Flavio Rocco, Maurizio Ceruti, Margherita Vono, Massimo Fresta & Donatella Paolino. (2012) Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases. International Journal of Nanomedicine 7, pages 2535-2546.
Read now
Read now
Patrick Roth, Agnieszka Korfel, Peter Martus & Michael Weller. (2012) Pathogenesis and management of primary CNS lymphoma. Expert Review of Anticancer Therapy 12:5, pages 623-633.
Read now
Read now
Bhupender S Chhikara & Keykavous Parang. (2010) Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opinion on Drug Delivery 7:12, pages 1399-1414.
Read now
Read now
Melanie Kripp & Ralf-Dieter Hofheinz. (2008) Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine. International Journal of Nanomedicine 3:4, pages 397-401.
Read now
Read now
Articles from other publishers (45)
Vanshita Singh, Akash Garg, Rajeev Sharma & Hitesh Kumar Dewangan. (2023) Recent Advances of Nanotechnology in Brain Targeting. Current Nanoscience 19:3, pages 350-361.
Crossref
Crossref
Jinu Mathew, Pallav Namdeo & Ashish Garg. 2023. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective
349
381
.
Lalit Kumar, Shivani Verma, Kajal Joshi & Sumit Sharma. (2023) Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:3, pages 47-94.
Crossref
Crossref
Raluca Ioana Teleanu, Manuela Daniela Preda, Adelina-Gabriela Niculescu, Oana Vladâcenco, Crina Ioana Radu, Alexandru Mihai Grumezescu & Daniel Mihai Teleanu. (2022) Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier. Pharmaceutics 14:5, pages 987.
Crossref
Crossref
Carely Hernandez & Surabhi Shukla. (2022) Liposome based drug delivery as a potential treatment option for Alzheimer’s disease. Neural Regeneration Research 17:6, pages 1190.
Crossref
Crossref
Reshu Virmani, Tarun Virmani & Kamla Pathak. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery
315
339
.
Firda Juhairiyah & Elizabeth C. M. de Lange. (2021) Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential. The AAPS Journal 23:6.
Crossref
Crossref
Pooria Nakhaei, Ria Margiana, Dmitry O. Bokov, Walid Kamal Abdelbasset, Mohammad Amin Jadidi Kouhbanani, Rajender S. Varma, Faroogh Marofi, Mostafa Jarahian & Nasrin Beheshtkhoo. (2021) Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Kelu Lei, Minghao Yuan, Tao Zhou, Qiang Ye, Bin Zeng, Qiang Zhou, Ailing Wei & Li Guo. (2021) Research progress in the application of bile acid-drug conjugates: A “trojan horse” strategy. Steroids 173, pages 108879.
Crossref
Crossref
Yujie Shi, An Lu, Xiangyu Wang, Zakia Belhadj, Jiancheng Wang & Qiang Zhang. (2021) A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharmaceutica Sinica B 11:8, pages 2396-2415.
Crossref
Crossref
Afrasim Moin, Syed Mohd Danish Rizvi, Talib Hussain, D. V. Gowda, Gehad M. Subaiea, Mustafa M. A. Elsayed, Mukhtar Ansari, Abulrahman Sattam Alanazi & Hemant Yadav. (2021) Current Status of Brain Tumor in the Kingdom of Saudi Arabia and Application of Nanobiotechnology for Its Treatment: A Comprehensive Review. Life 11:5, pages 421.
Crossref
Crossref
Ai-Mei Liao, Ying Zhang, Yinchen Hou, Ji-Hong Huang, Ming Hui, Kyung-Ku Lee, Kwang Youl Lee & ChangJu Chun. (2021) Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate. Food and Chemical Toxicology 151, pages 112101.
Crossref
Crossref
R.J.A. Vibhavari, Gautam Kumar, Vanishree Rao, Sri Pragnya Cheruku & Nitesh Kumar. 2021. Nano-Pharmacokinetics and Theranostics. Nano-Pharmacokinetics and Theranostics
117
152
.
Ying-Jie Hu, Rui-Jun Ju, Fan Zeng, Xian-Rong Qi & Wan-Liang Lu. 2021. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems
3
24
.
Hafsa Ahmad, Abhishek Arya, Satish Agrawal & Anil Kumar Dwivedi. 2021. Nanopharmaceuticals: Principles and Applications Vol. 1. Nanopharmaceuticals: Principles and Applications Vol. 1
1
71
.
Juan Tang, Na Wang, JingBo Wu, PeiRong Ren, JunYang Li, LiShi Yang, XiangXiang Shi, Yue Chen, ShaoZhi Fu & Sheng Lin. (2019) Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancer. Investigational New Drugs 37:6, pages 1146-1157.
Crossref
Crossref
Bahare Salehi, Zeliha Selamoglu, Ksenija S. Mileski, Raffaele Pezzani, Marco Redaelli, William C. Cho, Farzad Kobarfard, Sadegh Rajabi, Miquel Martorell, Pradeep Kumar, Natália Martins, Tuhin Subhra Santra & Javad Sharifi-Rad. (2019) Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules 9:12, pages 773.
Crossref
Crossref
Zi-Ying Wang, Sravan Gopalkrishnashetty Sreenivasmurthy, Ju-Xian Song, Jing-Yi Liu & Min Li. (2019) Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. Drug Discovery Today 24:2, pages 595-605.
Crossref
Crossref
Tang Li, Stephen Mudie, David Cipolla, Thomas Rades & Ben J. Boyd. (2018) Solid State Characterization of Ciprofloxacin Liposome Nanocrystals. Molecular Pharmaceutics 16:1, pages 184-194.
Crossref
Crossref
Gopalakrishna Pillai. 2019. Applications of Targeted Nano Drugs and Delivery Systems. Applications of Targeted Nano Drugs and Delivery Systems
221
256
.
Ying-Jie Hu, Rui-Jun Ju, Fan Zeng, Xian-Rong Qi & Wan-Liang Lu. 2019. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems
1
22
.
Chih Kit Chung, C.G. Da Silva, Dana Kralisch, Alan Chan, Ferry Ossendorp & Luis J. Cruz. (2018) Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences. Journal of Controlled Release 285, pages 56-66.
Crossref
Crossref
Carlos Rodríguez-Nogales, Yolanda González-Fernández, Azucena Aldaz, Patrick Couvreur & María J. Blanco-Prieto. (2018) Nanomedicines for Pediatric Cancers. ACS Nano 12:8, pages 7482-7496.
Crossref
Crossref
Li-Min Mu, Rui-Jun Ju, Rui Liu, Ying-Zi Bu, Jing-Ying Zhang, Xue-Qi Li, Fan Zeng & Wan-Liang Lu. (2017) Dual-functional drug liposomes in treatment of resistant cancers. Advanced Drug Delivery Reviews 115, pages 46-56.
Crossref
Crossref
E. González-Barca, M. Canales, A. Salar, J. J. Ferreiro-Martínez, S. Ferrer-Bordes, J. A. García-Marco, J. J. Sánchez-Blanco, J. García-Frade, J. Peñalver, J. L. Bello-López, J. M. Sancho & D. Caballero. (2016) Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial. Annals of Hematology 95:6, pages 893-899.
Crossref
Crossref
Amandine Segot, Emmanuel Raffoux, Etienne Lengline, Catherine Thieblemont, Hervé Dombret, Nicolas Boissel & Thomas Cluzeau. (2015) Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma. Annals of Hematology 94:11, pages 1859-1863.
Crossref
Crossref
Betiana Felice, Molamma P. Prabhakaran, Andrea P. Rodríguez & Seeram Ramakrishna. (2014) Drug delivery vehicles on a nano-engineering perspective. Materials Science and Engineering: C 41, pages 178-195.
Crossref
Crossref
Jaydev R. Upponi & Vladimir P. Torchilin. 2014. Nano-Oncologicals. Nano-Oncologicals
3
45
.
Gopalakrishna Pillai & Maria L Ceballos-Coronel. (2013) Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists. SAGE Open Medicine 1, pages 205031211351375.
Crossref
Crossref
David Chen & Sara Yazdi. 2013. Sterile Product Development. Sterile Product Development
47
60
.
Zsolt Kovács & Arpád Dobolyi. 2013. Adenosine. Adenosine
621
656
.
Alessandra Stacchini, Anna Demurtas & Sabrina Aliberti. (2012) Flow cytometric detection of liposomal cytarabine in cerebrospinal fluid of patients treated with intrathecal chemotherapy. Cytometry Part B: Clinical Cytometry 82B:5, pages 280-282.
Crossref
Crossref
Andrew Z. WangRobert Langer & Omid C. Farokhzad. (2012) Nanoparticle Delivery of Cancer Drugs. Annual Review of Medicine 63:1, pages 185-198.
Crossref
Crossref
Vladimir Torchilin. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery
289
328
.
Jai Grewal, Marlon Saria, Harpreet K Grewal & Santosh Kesari. (2011) Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome. Clinical Investigation 1:10, pages 1391-1402.
Crossref
Crossref
Arene Butto, Wajd N. Al-Holou, Larry Junck, Oren Sagher & Jeffrey J. Fletcher. (2011) Fulminant chemical ventriculomeningitis following intrathecal liposomal cytarabine administration. Journal of Clinical Neuroscience 18:10, pages 1417-1418.
Crossref
Crossref
Denis Buxton. 2011. Nanomedicine in Health and Disease. Nanomedicine in Health and Disease.
Nicola Gökbuget & Dieter Hoelzer. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy
217
227
.
Marc C Chamberlain. (2010) Leptomeningeal metastasis. Current Opinion in Oncology 22:6, pages 627-635.
Crossref
Crossref
Lorenzo Falchi, Marco Gunnellini, Laura Franco, Patrizia Ferrazza, Stefano Ascani & Anna Marina Liberati. (2009) Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy. Journal of Neuro-Oncology 97:1, pages 53-57.
Crossref
Crossref
Martin Benesch, Nele Siegler, Katja von Hoff, Lisa Lassay, Gabriele Kropshofer, Hermann Müller, Constanze Sommer, Stefan Rutkowski, Gudrun Fleischhack & Christian Urban. (2009) Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anti-Cancer Drugs 20:9, pages 794-799.
Crossref
Crossref
Alvaro Lassaletta, Blanca Lopez-Ibor, Elena Mateos, Marta Gonzalez-Vicent, Antonio Perez-Martinez, Julian Sevilla, Miguel A. Diaz & Luis Madero. (2009) Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors. Journal of Neuro-Oncology 95:1, pages 65-69.
Crossref
Crossref
Jennifer A. Smith & Michael Glantz. (2009) Statistical and Trial Design Considerations in Central Nervous System Prophylaxis Studies. Seminars in Oncology 36, pages S69-S76.
Crossref
Crossref
Pallavi Lagisetty, Prachi Vilekar & Vibhudutta Awasthi. (2009) Synthesis of radiolabeled cytarabine conjugates. Bioorganic & Medicinal Chemistry Letters 19:16, pages 4764-4767.
Crossref
Crossref
Elpis Mantadakis, Aspasia Katragkou, Eufrosini Papadaki, Stefanos Papadhimitriou, George Paterakis, Eftichia Stiakaki & Maria Kalmanti. (2008) Spinal cord compression in an adolescent with relapsed B-precursor acute lymphoblastic leukemia and mental neuropathy. International Journal of Hematology 88:3, pages 294-298.
Crossref
Crossref